Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
04/2012
04/19/2012US20120095030 Methods and kits to predict therapeutic outcome of tyrosine kinase inhibitors
04/19/2012US20120095029 Ipp complex as marker for erlotinib treatment
04/19/2012US20120095028 3-oxa-7-azabicyclo[3.3.1]nonanes
04/19/2012US20120095027 Synthesis and anti-proliferative effect of benzimidazole derivatives
04/19/2012US20120095026 Inhibitors of bruton's tyrosine kinase
04/19/2012US20120095025 SUBSTITUTED [1,2,4]TRIAZOLO[1,5-a]PYRIMIDINES AND THEIR USE AS POTASSIUM CHANNEL MODULATORS
04/19/2012US20120095024 Toluidine sulfonamides and their use
04/19/2012US20120095022 Derivatives of 10-amino-1,2,3,4-tetrahydropyrido[2,1-a]isoindol-6(10bh)-ones, method for preparation thereof and therapeutic uses thereof
04/19/2012US20120095021 Synthsis of new benzothiazole derivatives as potential anti-tubercular agents
04/19/2012US20120095020 Cathepsin S Inhibitor Compounds
04/19/2012US20120095019 Methods and formulations of treating thrombosis with betrixaban and a p-glycoprotein inhibitor
04/19/2012US20120095018 5-ht1a receptor subtype agonist
04/19/2012US20120095017 Pharmaceutical formulations of substituted azaindoleoxoacetic piperazine derivatives with protease inhibitors
04/19/2012US20120095016 Therapeutic 5,6,5-tricyclic analogs
04/19/2012US20120095015 Triazole compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor
04/19/2012US20120095014 Aminopyrimidines useful as kinase inhibitors
04/19/2012US20120095013 Use of kmup-3 for myocardial infarction
04/19/2012US20120095012 Toluidine sulfonamides and their use
04/19/2012US20120095011 Novel compounds
04/19/2012US20120095010 Tricyclic delta-opioid modulators
04/19/2012US20120095009 Synthesis and anti-proliferative effect of benzimidazole derivatives
04/19/2012US20120095008 Composition and methods for the treatment of wounds
04/19/2012US20120095007 Carbamoyloxy arylalkan arylpiperazine analgesics
04/19/2012US20120095006 Treatment of pulmonary hypertension
04/19/2012US20120095005 Fused Bicyclic Pyrazole Derivatives As Kinase Inhibitors
04/19/2012US20120095004 Sphingosine Kinase Inhibitors
04/19/2012US20120095003 Methods of using prodrugs of methyl hydrogen fumarate and pharmaceutical compositions thereof
04/19/2012US20120095002 Isoxazole-5-carboxamide derivatives
04/19/2012US20120095001 Substituted-1,3,8-triazaspiro[4.5]decane-2,4-diones
04/19/2012US20120095000 Compounds for activating tgf-beta signaling
04/19/2012US20120094999 Egfr inhibitors and methods of treating disorders
04/19/2012US20120094998 Oligomer-Protein Tyrosine Kinase Inhibitor Conjugates
04/19/2012US20120094997 Substituted hydroxamic acids and uses thereof
04/19/2012US20120094996 Imidazo [2, 1-B] [1, 3, 4] Thiadiazole Derivatives
04/19/2012US20120094995 2-aza-bicyclo[2.2.1]heptane compounds and uses thereof
04/19/2012US20120094994 Functionalized amino acids and absorbable polymers therefrom
04/19/2012US20120094993 N-pyridin-3-yl or n-pyrazin-2-yl carboxamides
04/19/2012US20120094992 Poly (adp-ribose) polymerase (parp) inhibitors
04/19/2012US20120094991 1, 4-Benzoxazine Compounds and Derivatives Thereof as Therapeutic Drugs for the Treatment of Neurodegenerative Conditions
04/19/2012US20120094990 Phenylacetic acid compound
04/19/2012US20120094989 5-ht receptor modulating compounds
04/19/2012US20120094987 SUBSTITUTED PYRIDO [3', 2': 4, 5] THIENO [3, 2-D] PYRIMIDINES AND PYRIDO [3', 2': 4, 5] FURO [3, 2-D] PYRIMIDINES USED AS INHIBITORS OF THE PDE-4 AND/OR THE RELEASE OF TNF-alpha
04/19/2012US20120094986 Anticancer deriviatives, preparation thereof, and therapeutic use thereof
04/19/2012US20120094985 Pharmaceutical compositions comprising chlorophenyl piperazine derived compounds and use of the compounds in producing medicaments
04/19/2012US20120094984 Fused aminodihydrothiazine derivatives
04/19/2012US20120094983 Acyclic ikur inhibitors
04/19/2012US20120094982 1,4-benzodiazepinone compounds and their use in treating cancer
04/19/2012US20120094981 Anthelmintic agents and their use
04/19/2012US20120094980 Pyridyl inhibitors of hedgehog signalling
04/19/2012US20120094979 Thiazole or thiadizaloe derivatives for use as sphingosine 1-phosphate 1 (s1p1) receptor agonists
04/19/2012US20120094978 Ocular Allergy Treatments
04/19/2012US20120094977 Compositions and methods for the treatment of disease associated with trp-p8 expression
04/19/2012US20120094976 New chemical compounds
04/19/2012US20120094975 Pyrido [5, 4-d] pyrimidines as cell proliferation inhibitors
04/19/2012US20120094974 Smoothened receptor modulators
04/19/2012US20120094973 Catechol-based derivatives for treating or preventing diabetics
04/19/2012US20120094972 Heterocyclic compounds and their uses
04/19/2012US20120094971 Compositions Including 6-Aminohexanoic Acid Derivatives As HDAC Inhibitors
04/19/2012US20120094970 NON-HORMONAL STEROID MODULATORS OF NF-kB FOR TREATMENT OF DISEASE
04/19/2012US20120094969 17-hydroxy-17-pentafluoroethyl-estra-4,9(10)-dien-11-aryl derivatives, method of production thereof and use thereof for the treatment of diseases
04/19/2012US20120094968 Sulfonic amide and sulfoximine-substttuted diaryl-dihydropyrimidinones and usage thereof
04/19/2012US20120094967 Compositions and methods for treating asthma and other lung diseases
04/19/2012US20120094966 Organic compounds
04/19/2012US20120094965 Method and Formulation for Chemical Peeling
04/19/2012US20120094964 Sulfamoyl benzoic acid derivatives as trpm8 antagonists
04/19/2012US20120094963 Targeting prodrugs and compositions for the treatment of gastrointestinal diseases
04/19/2012US20120094962 Pharmaceutical composition for use in medical and veterinary ophthalmology
04/19/2012US20120094961 Tumor eradication by inositol-tripyrophosphate
04/19/2012US20120094960 Dosage forms of risedronate
04/19/2012US20120094959 Treatment of cystic diseases
04/19/2012US20120094958 Quinolines as inhibitors of farnesyl pyrophosphate synthase
04/19/2012US20120094957 Inhibitors of fatty acid amide hydrolase
04/19/2012US20120094956 Treatment of Cancer with Specific RXR Agonists
04/19/2012US20120094955 Method of dissolving an oxidized polysaccharide in an aqueous solution
04/19/2012US20120094954 Compositions comprising at least one complex composed of a derivative of naphthoic acid and of at least one cyclodextrin and uses thereof
04/19/2012US20120094953 Process for the production of nano-fibrillar cellulose suspensions
04/19/2012US20120094952 Polysialic Acid Derivatives, Methods of Production, and Uses in Enhancing Cancer Antigen Production and Targeting
04/19/2012US20120094951 Compositions
04/19/2012US20120094950 Nutraceutical Composition and Methods for Preventing or Treating Multiple Sclerosis
04/19/2012US20120094949 Histone modification patterns for clinical diagnosis and prognosis of cancer
04/19/2012US20120094948 Analogous Compounds of 6-Thioguanosine Triphosphate, their use in Medical Fields and Processes for their Preparation
04/19/2012US20120094947 Method for the selective therapy of disease
04/19/2012US20120094946 Glycosylated chlorambucil analogs and uses thereof
04/19/2012US20120094945 Discovery of Selective Glucocorticoid Receptor Modulators by Multiplexed Reporter Screening
04/19/2012US20120094944 Novel imidazopyridine compound
04/19/2012US20120094943 Alpha 7 nicotinic receptor selective ligands
04/19/2012US20120094942 Chemosensory Receptor Ligand-Based Therapies
04/19/2012US20120094941 Mangiferin-Berberine Salt, Manufacturing Method and Use Thereof
04/19/2012US20120094940 Process of producing sugar composition comprising definite amount of target hexose and having sugar constitution different from that of starting sugar material and use of produced sugar composition
04/19/2012US20120094939 Anti-viral compounds, compositions and methods
04/19/2012US20120094934 Treatment of tumor necrosis factor receptor 2 (tnfr2) related diseases by inhibition of natural antisense transcript to tnfr2
04/19/2012US20120094932 Macrocyclic lactone compounds and methods for their use
04/19/2012US20120094927 Therapy for mll-rearranged leukemia
04/19/2012US20120094925 Insulin-like growth factor binding protein 7 for treatment of cancer
04/19/2012US20120094918 Method of using diketopiperazines and composition containing them
04/19/2012US20120094913 Novel ppar ligands that do not cause fluid retention, edema or congestive heart failure
04/19/2012US20120094900 Sensitizing agents for cancer therapy, methods of use and methods for the identification thereof
04/19/2012US20120094894 Antidiabetic medications comprising a dpp-4 inhibitor (linagliptin) optionally in combination with other antidiabetics
04/19/2012US20120094893 Method of using diketopiperazines and composition containing them
04/19/2012US20120093952 Use of essential oil compounds as histomonastat
1 ... 1267 1268 1269 1270 1271 1272 1273 1274 1275 1276 1277 1278 1279 1280 1281 1282 1283 1284 1285 1286 1287 ... 7860